(123)I-mIBG scintigraphy in neuroblastoma: development of a SIOPEN semi-quantitative reporting, method by an international panel

Written By Carla Aguilera

Lewington V, Lambert B, Poetschger U, Sever ZB, Giammarile F, McEwan AJB, Castellani R, Lynch T, Shulkin B, Drobics M, Staudenherz A, Ladenstein R.

Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):234-241. doi: 10.1007/s00259-016-3516-0. Epub 2016 Sep 24. PMID: 27663238; PMCID: PMC5214990.

Carla Aguilera
Previous

Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma …
Next

Outcome of children with relapsed or refractory neuroblastoma: A meta-analysis of ITCC/SIOPEN European phase II clinical trials